LW158 IMP Support (FAME)
Estimated value
—
Awarded value
£1
Suppliers
1
Lots
1
Published
17 Mar 2026
Description
The purpose of this project is to appoint a supplier to handle the receipt of clinical trial Investigational Medicinal Product (IMP) from manufacturer, import, labelling, and distribution to the in-country sites/teams. The trial will be running in Cameroon and involves three oral drugs. Initial dose will be delivered to remote community clinic or healthcare facility and subsequent doses stored and given from the hospital site during the participant admission.
Scope
- Reference
- LW158
- Commercial tool
- Standalone contract
- Contract dates
- 01 Feb 2026 to 31 Dec 2029Possible extension to 31 Dec 2031
The Contract may be extended beyond the Initial Term on a maximum of 2 (two) occasions, for a period of up to 1 (one) year on each occasion.
- CPV classifications
- 336000003369800079920000
- Contract locations
- North West England, United KingdomCM, Cameroon
- Particular suitability
- Small and medium-sized enterprises (SME)Voluntary, community and social enterprises (VCSE)
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Technical | — | quality | 70.00% |
| Commercial | — | price | 30.00% |
Submission & procedure
- Procedure
- Below threshold - open competition
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£1
Award date
17 Mar 2026
Contract start
23 Mar 2026
Contract end
22 Mar 2029